Five Star Equities Provides Stock Research on Exelixis and Lexicon Pharmaceuticals
Continue ReadingTag: equity-research
Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success
RDInvesting Provides Stocks Research on Cadence Pharmaceuticals and Opexa Therapeutics
Continue Reading
Expanding Pipelines Sends Margin Between West Texas Intermediate and Brent Crude to Narrowest in 8 Months
RDInvesting Provides Stock Research on Bill Barrett and Goodrich Petroleum
Continue Reading
FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval after Just 1 Round of Testing
Five Star Equities Provides Stock Research on Oncolytics Biotech and XOMA
Continue Reading
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
RDInvesting Provides Stocks Research on Protalix BioTherapeutics and Supernus Pharmaceuticals
Continue Reading
New Programs Designed to Speed up Approval Process a Key Factor in Biotech Industry-s Growth in 2012
Five Star Equities Provides Stock Research on ImmunoCellular and Nektar
Continue Reading
Natural Gas Prices Surging in 2013 Due to Warm Weather and Falling Supplies
Five Star Equities Provides Stock Research on Quicksilver Resources and Cheniere Energy
Continue Reading
Shares of Foreign Banking Stocks Fall as Cyprus Proposes Deposit Tax
RDInvesting Provides Stock Research on Banco Santander and Banco Bilbao Vizcaya Argentaria
Continue Reading
Natural Gas Producers Surge as Futures Reach a 16-Month High
Five Star Equities Provides Stock Research on Chesapeake Energy and Southwestern Energy
Continue Reading
Cyprus Proposes Tax on Deposits — Concerns Mount That Other Struggling Countries May Follow
RDInvesting Provides Stock Research on Lloyds Banking Group and National Bank of Greece
Continue Reading